U.S. Senate Convenes Historic Roundtable on Aging Research

Global Coalition on Aging Leads Call to Action for Federal Research Priorities

WASHINGTON, DC (October 31, 2013) — Global Coalition on Aging (GCOA) Executive Director Michael W. Hodin, PhD, led a discussion with  the U.S. Senate Special Committee on Aging’s Members’ Roundtable on the nation’s most pressing needs around aging demographics. The October 29 roundtable was called by Committee Chairman Bill Nelson (D-FL) and included a diverse panel of leading medical and scientific experts on aging and the explosion of non-communicable diseases (NCDs), which increase with age.

“For the first time, our country is reevaluating and resetting its priorities for national research, which is leading to a massive shift in how we fund NCD research in order to give us a healthier and more active aging,” said Hodin. “How we fund aging research is our biggest fiscal challenge and economic opportunity. If we can bend the curve on diseases that strike us as we age – Alzheimer’s disease, diabetes, cancer, cardiovascular disease – and those physical capabilities that deteriorate as we age – our skin, vision, muscle capacity – we will transform how we live.”

Expert testimony from each of the panelists established the case not only for funding to enhance U.S. scientific competitiveness, but also for developing more coordinated research strategies across all sectors to better understand, address and cure NCDs.  According to the Gerontological Society of America, today less than one percent of the National Institutes of Health annual budget funds research into the underlying biology of aging and its role in the onset of disease.

Increased longevity, while challenging, also presents incredible opportunity. “The opportunity of population aging can be achieved through smarter spending on our health today,” said Hodin. “To truly change the paradigm of aging from one automatically associated with disease and disability to a healthier and happier process, we must view this spending as an investment – as we did in our spending on the space program, the interstate highway system and our nation’s children.”

“Medical research on ways to improve the health of our nation’s aging population should be a top priority. The need to increase collaboration among researchers has never been more important,” said Sen. Nelson during the roundtable.  Citing recently reduced research budgets due to sequestration, he noted the critical nature of the NIH to “our nation’s fiscal and physical health.”

Currently, a National Institutes of Health (NIH) initiative is underway aimed at achieving four goals:

  1. Increasing collaboration across institutes involved in aging research;
  2. Uncovering how similar cross-cutting collaboration is beginning to occur in the university setting and in the private sector;
  3. Highlighting scientific areas where an aging-oriented approach to ameliorating disease is promising and where disease-specific research is beneficial; and
  4. Enabling a better understand of how delaying or preventing age-related chronic diseases can help bend the health care cost curve.

The roundtable preceded and helped inform the October 30-November 1 NIH Geroscience Interest Group (GSIG) Summit titled “Advances in Geroscience: Impact on Healthspan and Chronic Disease.” The summit welcomes 500 scientists from academic research centers from around the country.

The GSIG is a recently formed group focused on “geroscience,” the study of the relationship between aging and age-related disease and disability and is among the largest trans-NIH interest groups. The summit was opened by Dr. Francis Collins, Director of the NIH.

GCOA applauds the Senate Special Committee on Aging for holding the roundtable, in particular Sen. Nelson, Ranking Member Susan Collins (R-ME), Sen. Elizabeth Warren (D-MA), and Sen. Joe Donnelly (D-IN).  We also congratulate the NIH, the Alliance for Aging Research and the Gerontological Society of America for leading the GSIG summit.

The roundtable participants were:

  • Richard Hodes, MD, Director, National Institute on Aging, National Institutes of Health
  • John Alam, MD, Head, Therapeutic Strategic Area for Diseases of Aging, Sanofi-Aventis
  • James Kirkland, MD, PhD, Professor, Noaber Foundation Professor of Aging Research and Director, Robert and Arlene Kogod Center on Aging, Mayo Clinic
  • Richard Morimoto, PhD, Professor, Department of Molecular Biosciences and Director, Rice Institute for Biomedical Research, Northwestern University
  • David Morgan, PhD, Chief Executive Officer and Director, Byrd Alzheimer Institute and Director of Neuroscience Research, University of South Florida College of Medicine

For more information about the roundtable, click here for the Committee’s website.

Latest Developments

We keep our members and partners in touch with the most recent updates and opinions in the worldwide dialogue on population longevity and related issues.

Global Coalition on Aging Workshop Calls on G7 Countries to Fund Pull Incentives to Spur Antibiotic Innovation

The Global Coalition on Aging, in partnership with JPMA, today announced the release of its workshop report on the AMR crisis facing G7 countries and the world, “The Value of Pull Incentives in Japan to Encourage Investment in Antibiotic Innovation to Solve the AMR Crisis.” If strong action is not taken to address AMR, we will lose the antibiotics we need to cure infections, which is likely to outpace cancer as a major cause of death, killing an estimated 10 million by 2050.

Our National Conversation on Aging

Now that President Biden officially declared his run for a second term, what are we to make of the countless warnings about his age? Clearly, voters have already considered age a major factor – Google Search results for ‘Biden age’ hit an all-time-high just before the 2020 election – and speculation has only heightened four years on. Unfortunately, these concerns are misguided and even dangerous because they conflate age with poor health and confuse ideas about work and retirement.

World Immunization Week: Best-Kept Secret for 21st-Century Healthy Aging

The tremendous success of childhood immunisation campaigns across the 20thcentury is one of the greatest triumphs of public health. Along with advances in sanitation and antibiotics, childhood immunisation has resulted in the miracle of modern longevity: the once extravagant prospect of growing old has become the norm. Now, in our 21st century, isn’t it our great challenge to build on this achievement by realising a healthy longevity?

South China Morning Post Letter to the Editor

Antimicrobial resistance is one of the defining global problems of our time. Drug-resistant bacterial infections killed an estimated 1.27 million people in 2019. By 2050, 10 million lives annually could be lost to antimicrobial resistance, and annual global gross domestic product could fall by between 1.1 per cent and 3.8 per cent. Fortunately, Chinese policymakers, physicians and patients have shown what is possible when they focus collective efforts on antimicrobial resistance.

Medicine Price Setting Might Appeal to Voters but Will Cost Patients

As policymakers search for potential cuts to the national budget, they risk jeopardizing the country’s most cost-effective use of healthcare dollars: biomedical innovation regarding vaccines , prescription drugs, and emerging therapies, including antibodies. As the nation rapidly ages, protecting this pipeline of medicine will not only improve health outcomes but will do so at a lower cost by reducing more expensive hospital and primary care.

Global Coalition on Aging Hosts Cross-Sector Roundtable to Tackle Heart Valve Disease in Aging Societies

The Global Coalition on Aging (GCOA) and the Global Heart Hub have released a global position paper “Heart Valve Disease: Harnessing Innovation to Save Lives, Mitigate Costs, and Advance the Healthy Aging Agenda.” The report builds upon on a December 2022 GCOA-GHH roundtable of cross-sector experts and examines how behavior and policy change can best address heart valve disease in our 21st century.

New York City Twins with Ireland to Develop Age Friendly Communities

The twinning commits both sides to share knowledge on age friendly programs and builds on the 2011 Dublin Declaration of Age-Friendly Cities and Communities. The agreement was signed by the Cathaoirleach (Mayor) Nick Killian of Meath County Council which hosts the Irish Age Friendly Programme and Lorraine Cortés-Vázquez, Commissioner for Aging.

Just Getting Started at 75

In the latest charge against the promise of healthy aging, Dr. Ezekiel Emanuel, oncologist and bioethicist, doubled down on his infamous 2014 essay stating that 75 is the ideal age to die. Now 65, he maintains that after age 75, he will no longer receive medical screenings and interventions like colonoscopies, cancer treatment, flu shots, and heart valve replacement.